The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial (Q41847223)
Jump to navigation
Jump to search
scientific article published on 20 February 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial |
scientific article published on 20 February 2017 |
Statements
1 reference
The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial (English)
1 reference
David Derthoo
Olivier Van Caenegem
Michel De Pauw
Eric Nellessen
Nathalie Duerinckx
Walter Droogne
Gábor Vörös
Bart Meyns
Ann Belmans
Stefan Janssens
Johan Vanhaecke
20 February 2017
1 reference
1 reference
1 reference
1 reference